黄璐博士-讲师
发布时间：2025-10-13 浏览次数：0次
黄璐，女，中共党员。2024年6月博士毕业于188bet金宝博 药剂学专业。主要从事新型药物递送系统的研究开发，独立或合作开展了多项纳米递送体系相关课题。
科研项目：
1.国家自然科学基金“蛋白酶可触发的改性离子通道门控系统的设计及其在肿瘤治疗中的应用”（81973251），参与；
2.河北省人力资源和社会保障厅资助项目“抗肿瘤纳米核酸药物的研究”（C20230351），参与；
3.河北省京津冀协同创新专项“RNA药物递送平台的工程化构建及其抗血液系统肿瘤应用研究”（25242701D），参与。
代表性论文：
1. Huang Lu, Guo Wen-li, Zhao Ting, Feng Yan-ru, Li Yue, An Qing-qing, Li Chen-xi, Tian Yi-wei, Zhang Hua-xing, Zhou Chen-ming, Sun Ya-nan, He Chao-xing, Niu Zhi-yun***, Shen Hai-tao**, Xiang Bai*. Microfluidic fabrication of lipid nanoparticles for co-delivery of siRNA and hydroxychloroquine: an engineered theranostic platform for enhanced breast cancer treatment. Chemical Engineering Journal, 2025, 506: 160172.
2. Hao Jin-tao, Li Yue, Huang Lu, Qi Nan-nan, Sun Ya-nan, He Chao-xing, Yang Shao-kun, Niu Zhi-yun, Qi Xian-rong**, Xiang Bai*. Smart Nanoarchitectures for Precision RNA Delivery: Harnessing Endogenous and Exogenous Stimuli in Cancer Treatment. Theranostics, 2025, 15(15): 7747-7778.
3. Sun Ya-nan, Xi Yu-meng ,Yu Yue-tong, Huang Lu, Li Yue, Song Yu-pin, Liu Meng-yang, Yang Shao-kun, He Chao-xing, Dai Wen-bing, Zhang Hai-lin**, Xiang Bai*. Cathepsin B/pH cascade-responsive transformable peptide: Orchestrating endo/lysosomal escape and cytoplasmic release of siRNA to enhance tumor therapy. Chemical Engineering Journal, 2025, 522: 167455.
4. Liu Meng-yang, Xing Rui-juan, Chen Ge, Liang Yu-xiang, Huang Lu, Xi Yu-meng, Li Yue, zhang shi-fei, Sun Ya-nan, Song Yu-pin, Hao jin-tao, Cong Ke-xin, He chao-xing, Yang shao-kun, Xiang Bai**, Wang Lei*. Branched ligand-functionalized immuno-evasive PEGylation (BLIP) platform: Breaking through accelerated blood clearance and chemoresistance barriers with dual-targeting RNAi-chemotherapy synergy. Chemical Engineering Journal, 2025, 522, 167098.
5. Feng Yan-ru, Pan Xin-tong, Li Zi-qian, Li Yue, Sun Ya-nan, Yang Shao-kun, He Chao-xing, Dang Yun-jie, Huang Lu**, Xiang Bai*. Innovative lipid nanoparticles co-delivering hydroxychloroquine and siRNA for enhanced rheumatoid arthritis therapy. Pharmaceutics, 2025, 17(1): 45.